FDA has authorized and CDC has recommended a single booster dose of Monovalent Novavax COVID-19 Vaccine for people ages 18 years and older who have completed their primary vaccination and have not received any previous booster dose(s).

Eligibility

• At least 18 years of age AND
• Completed a primary COVID-19 vaccine series with any FDA-approved or FDA-authorized monovalent COVID-19 vaccine AND
• Has not received any booster doses of COVID-19 vaccine AND
• Unable (e.g., mRNA vaccine contraindicated or not available) or unwilling to receive an mRNA vaccine; would otherwise not receive a COVID-19 booster dose.

Timing

Administer a booster dose of Monovalent Novavax COVID-19 Vaccine at least 6 months after completion of a primary series.